Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000249573 | SCV000316036 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000525814 | SCV000414554 | benign | Familial cold autoinflammatory syndrome 2 | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Invitae | RCV000525814 | SCV000646339 | benign | Familial cold autoinflammatory syndrome 2 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000525814 | SCV000782479 | uncertain significance | Familial cold autoinflammatory syndrome 2 | 2016-08-02 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000525814 | SCV001142151 | benign | Familial cold autoinflammatory syndrome 2 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000525814 | SCV001160583 | likely benign | Familial cold autoinflammatory syndrome 2 | 2023-10-09 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002262907 | SCV002542574 | benign | Autoinflammatory syndrome | 2022-05-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001706385 | SCV002543975 | benign | not provided | 2023-07-01 | criteria provided, single submitter | clinical testing | NLRP12: BP4, BS1, BS2 |
Center for Genomics, |
RCV000525814 | SCV003920284 | likely benign | Familial cold autoinflammatory syndrome 2 | 2022-10-13 | criteria provided, single submitter | clinical testing | This variant has been reported in the literature in several individuals with features of immunodeficiency or autoimmunity, including periodic fevers, in the heterozygous and compound heterozygous state (Borte 2014 PMID: 25064829, Rusmini 2016 PMID: 26386126, Cetinkaya 2018 PMID: 29307770, Kostik 2018 PMID: 29500522, Ledesma 2019 PMID: 31836009, Suspitsin 2020 PMID: 32441320). This variant is present in the Genome Aggregation Database (Highest reported MAF: 2.1% [515/25100], including 3 homozygotes; https://gnomad.broadinstitute.org/variant/19-54314003-G-A?dataset=gnomad_r2_1). This variant is present in ClinVar, with several labs classifying this variant as likely benign or benign (Variation ID: 262532). Evolutionary conservation and computational predictive tools suggest that this variant may impact the protein. In summary, data on this variant suggests that this variant does not cause Mendelian disease but requires further evidence. Therefore, this variant is classified as likely benign. |
Genome Diagnostics Laboratory, |
RCV001706385 | SCV001926731 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001706385 | SCV001971397 | likely benign | not provided | no assertion criteria provided | clinical testing |